Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94121


Purpose:

The proposed study tests the efficacy of using pager-assisted messages combined with nicotine patches in facilitating smoking cessation and relapse prevention in a 2-arm randomized clinical trial. The hypothesis is that the proportion of biochemically-verified quitters at 3 and 12 months in the study arm randomized to receive therapeutic messages on alphanumeric pagers for 3 months along with individual smoking cessation counseling and nicotine patches will be greater that the proportion of biochemically-verified quitters who receive only individual smoking cessation counseling and nicotine patches.


Study summary:

A total of 224 current smokers were enrolled in a randomized controlled smoking cessation trial. Participants were community-living adult smokers of ≥10 cigarettes per day during the pre-enrollment week who were interested in quitting and recruited from the local area by means of print, media, and online advertisements. To be eligible, they needed to be smoking 10 or more cigarettes per day, aged 18 or older, motivated to quit smoking, prepared to set a quit date, willing to use nicotine patches, and able to come to therapy sessions and be followed by telephone. Participants in the pager treatment were provided with alpha-numeric pagers free of charge for three months. Using specially-designed communication software, text messages were sent to participants aimed at facilitating motivation to quit, cessation strategies, and coping skills to maintain abstinence. Participants in both treatment groups were seen for two 60-minute sessions of standard smoking cessation counseling, and received three follow-up phone calls and two months of nicotine patches.


Criteria:

Inclusion Criteria: - smoking 10 or more cigarettes per day - aged 18 or older - motivated to quit smoking and prepared to set a quit date - willing to use nicotine patches - ability to come to therapy sessions and be followed by telephone Exclusion Criteria: - individuals who are psychotic - severely depressed - organically brain impaired - actively abusing alcohol or other substances, and/or who have been drug dependent during the past six months - terminally ill - unable to be contacted by phone,currently using nicotine replacement or smoking cessation medications - those with contraindications to nicotine patches, female smokers who are pregnant or breastfeeding


NCT ID:

NCT01207310


Primary Contact:

Principal Investigator
Timothy P Carmody, Ph.D
University of California, San Francisco


Backup Contact:

N/A


Location Contact:

San Francisco, California 94121
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.